1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Observational: new trials by email Literature Review of Observational trials Research Report on Observational
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants BNT162b2, Multivalent BNT162b2 (B.1.1.7 + B.1.617.2), Monovalent BNT162b2 (B.1.1.7) - SARS-CoV-2 Infection, COVID-19 | Phase 2 | Completed | BioNTech SE | 1380 | 2021-08-25 | 2024-11-22 |
| 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) 4D-125 IVT Injection, Observational - X-Linked Retinitis Pigmentosa | Phase 1 / Phase 2 | Active not recruiting | 4D Molecular Therapeutics | 21 | 2020-06-09 | 2025-03-21 |
COVID-19 (1) · Disease (1) · Severe Acute Respiratory Syndrome (1)
4D Molecular Therapeutics (1) · BioNTech SE (1)
United States (2) · Germany (1) · South Africa (1) · Turkey (Türkiye) (1)
Schonmei Lee, MD (1)